A share of I-Mab (NASDAQ:IMAB) closed at $8.53 per share on Monday, down from $10.48 day before. While I-Mab has underperformed by -18.61%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, IMAB fell by -89.08%, with highs and lows ranging from $81.05 to $8.05, whereas the simple moving average fell by -70.67% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
On December 09, 2021, Siebert Williams Shank started tracking I-Mab (NASDAQ: IMAB) recommending Buy. A report published by Daiwa Securities on June 02, 2021, Initiated its previous ‘Buy’ rating for IMAB. Needham also rated IMAB shares as ‘Buy’, setting a target price of $75 on the company’s shares in an initiating report dated March 15, 2021. H.C. Wainwright Reiterated the rating as Buy on March 03, 2021, but set its price target from $55 to $75. Piper Sandler initiated its ‘Overweight’ rating for IMAB, as published in its report on February 25, 2021. H.C. Wainwright’s report from December 07, 2020 suggests a price prediction of $55 for IMAB shares, giving the stock a ‘Buy’ rating. Cantor Fitzgerald also rated the stock as ‘Overweight’.
Analysis of I-Mab (IMAB)
Further, the quarter-over-quarter decrease in sales is -97.70%, showing a negative trend in the upcoming months.
I-Mab’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -48.10% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.60, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and IMAB is registering an average volume of 891.36K. On a monthly basis, the volatility of the stock is set at 9.85%, whereas on a weekly basis, it is put at 15.63%, with a loss of -19.68% over the past seven days. Furthermore, long-term investors anticipate a median target price of $75.01, showing growth from the present price of $8.53, which can serve as yet another indication of whether IMAB is worth investing in or should be passed over.
How Do You Analyze I-Mab Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.07%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 63.60% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in IMAB shares?
The recent increase in stakes in IMAB appears to be a result of several institutional investors and hedge funds increasing their positions. HHLR Advisors Ltd.’s position in IMAB has decreased by 0.00% in the first quarter. The company now owns 7,182,850 shares of the stock, with a value of $81.17 million, following the sale of 0 additional shares during the last quarter. T. Rowe Price Associates, Inc. made another decreased to its shares in IMAB during the first quarter, downing its stake by -26.58%. During the last quarter, the company dropped down -1,953,615 additional shares for a total stake of worth $60.97 million, bringing number of shares owned by the company to 5,395,157.
During the first quarter, Cederberg Capital Ltd. subtracted a -105,885 position in IMAB. BlackRock Fund Advisors sold an additional 71260.0 shares in the last quarter, decreasing its holdings by -3.57%, now holding 1.92 million shares worth $21.72 million. At the end of the first quarter, Morgan Stanley & Co. LLC increased its IMAB holdings by 11.41% and now holds 1.59 million IMAB shares valued at $18.01 million with the added 0.16 million shares during the period. IMAB shares are owned by institutional investors to the tune of 63.60% at present.
